The Platform Group AG header image

The Platform Group AG

TPG

Equity

ISIN DE000A2QEFA1 / Valor 57796644

Xetra (2025-04-10)
EUR 8.58+0.94%

The Platform Group AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

The Platform Group AG, established in 2012 by Dr. Dominik Benner, is a prominent European company specializing in software-based platform solutions that facilitate eCommerce for both B2B and B2C markets. Initially launched with the platform schuhe24.de to transition a family shoe store into the online space, the company has since expanded to operate 30 platforms across 25 sectors. These platforms enable retailers and manufacturers to list their products on over 50 online channels, streamlining the eCommerce process by handling content, pricing, delivery, and customs. The Platform Group AG's software solutions are designed to digitize traditional businesses, offering a comprehensive ecosystem that minimizes the effort required from partners while maximizing their online trading capabilities. The company's innovative approach connects analog businesses to the digital marketplace, leveraging a decade of software development to support diverse industries.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Strong Sales Growth

The Platform Group AG reported strong sales growth for the first quarter of 2024. The company saw a significant increase in sales, which has led to an upward revision of its annual forecast for the year. This growth is attributed to the successful integration of recent acquisitions and the expansion of its market presence.

Increased Earnings

In Q1 2024, The Platform Group AG experienced a notable increase in earnings. The company's earnings surpassed initial forecasts, reflecting the effectiveness of its strategic initiatives and operational efficiencies. This positive performance has bolstered investor confidence and set a promising tone for the rest of the year.

Positive Outlook

The Platform Group AG has confirmed a positive outlook for the remainder of 2024. Following the strong financial results in the first quarter, the company remains optimistic about its growth prospects. The management has reiterated its commitment to achieving its medium-term financial targets and delivering value to shareholders.

Dividend Announcement

Based on the robust financial performance in Q1 2024, The Platform Group AG has announced a dividend for its shareholders. This decision underscores the company's strong cash flow position and its dedication to returning capital to investors. The dividend is expected to be well-received by the market.

Revenue Increase

The Platform Group AG reported a significant increase in revenue for the first quarter of 2024. The revenue growth was driven by higher sales volumes and successful market expansion strategies. This increase in revenue has contributed to the overall financial strength of the company and supports its growth trajectory.

Summarized from source with an LLMView Source

Key figures

15.6%1Y
14.9%3Y
%5Y

Performance

35.6%1Y
53.5%3Y
53.3%5Y

Volatility

Market cap

49 M

Market cap (USD)

Daily traded volume (Shares)

25,348

Daily traded volume (Shares)

1 day high/low

7.64 / 7.52

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.91%USD 338.53
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.64%GBP 17.74
Sonova Holding Ltd.
Sonova Holding Ltd. Sonova Holding Ltd. Valor: 1254978
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.48%CHF 228.00
Takeda Yakuhin Kogyo KK
Takeda Yakuhin Kogyo KK Takeda Yakuhin Kogyo KK Valor: 11292411
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.99%USD 14.34
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.40%USD 103.20
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
12.82%USD 35.12
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.42%USD 103.84
Addus HomeCare Corp
Addus HomeCare Corp Addus HomeCare Corp Valor: 10385048
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.86%USD 101.00
Addex Therapeutics Ltd
Addex Therapeutics Ltd Addex Therapeutics Ltd Valor: 2985075
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-11.11%CHF 0.048
CRISPR Therapeutics Ltd
CRISPR Therapeutics Ltd CRISPR Therapeutics Ltd Valor: 33408113
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
11.58%USD 34.89